SGX Listed Stock

YONGNAM HOLDINGS LIMITED (SGX:AXB)


SGD 0.173
+0.004 / +2.37%
Share Price as of: 2018-12-14 17:06
Market / ISIN Code: SGX Mainboard / SG1BA3000001
GICS® Sector / Industry Group / Industry: Industrials / Capital Goods / Construction and Engineering


Yongnam Blogger ArticlesYONGNAM HOLDINGS LIMITED Blogger Articles SGX Listed YONGNAM HOLDINGS LIMITED (SGX:AXB) Blogger Articles AXB.SI Blogger Articles
The Motley Fool Singapore
Chong Ser Jing
2018-11-16 09:43:31
2 Companies Which Have Reported Gross Losses And What You Can Learn From Them
The importance of the gross margin in assessing a company’s financial status and competitive moat cannot be understated. My colleague Royston Yang had previously written an article on the gross profit margin and its usefulness. If a company reports a negative gross profit margin, it implies that the selling price of its goods or services is lower than the cost it took to manufacture its products or provide its services. Such a situation is fairly uncommon as most companies are able to price their products above their costs. In this article, I would like to explore two companies which had recently reported negative gross profit (or a gross loss), resulting in a negative gross profit margin. I will end off with what we can learn from these examples and how we should think about compani
The Motley Fool Singapore
Sudhan P.
2018-08-21 07:37:09
National Day Rally 2018: These Singapore-Listed Companies Could Benefit (Or Be Affected)
On Sunday, 20 August 2018, Prime Minister (PM) Lee Hsien Loong gave his National Day Rally speech at the Institute of Technical Education College Central campus in Ang Mo Kio. He touched on various topics, such as the cost of living, housing and healthcare in Singapore, among others. Some Singapore-listed companies could benefit (or be affected) from the plans laid out during the rally. Let’s take a look. Healthcare – CHAS extension and the new Merdeka Generation Package PM Lee announced that the Community Health Assist Scheme (CHAS) will be extended to all Singaporeans with chronic conditions, regardless of income. The level of benefits, however, will continue to depend on the individual’s income. CHAS, which previously covered only middle to lower-income Singaporeans, provides subs





Investment BloggerSG Investment BlogSG Invest BloggersBloggers Say








Your Say










Stock / REIT Search

Advertisement

Advertisement